Randomized clinical trial to assess the effectiveness and tolerability of Mela B3 serum in combination with 35% glycolic acid peel vs. 35% glycolic acid peel for the treatment of various hyperpigmentation conditions (melasma, post-inflammatory hyperpigmentation and solar lentigo) and signs of aging in a population of participants from the Autonomous City of Buenos Aires, Argentina.
Women and men
From 30 to 70 years of age (inclusive)
Good general health
With any type of phototype
Pregnant, breastfeeding or with pregnancy plans.
All contraindications for superficial peeling (for example, concomitant infectious processes or inflammatory processes that affect the skin barrier).
Melasma with predominance of the pigmentary component at the dermis level, observed with Wood's light at the inclusion visit.
Active acne with 10 or more inflammatory lesions.